RecruitingPhase 3NCT04268524

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medecins Sans Frontieres, Netherlands
Principal Investigator
Koert Ritmeijer
Medecins Sans Frontieres, Netherlands
Intervention
drug: miltefosine with thermotherapy(combination_product)
Enrollment
832 target
Eligibility
10 years · All sexes
Timeline
2022 – 2026

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04268524 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis →

← Back to all trials